AMBROSETTI, Achille
 Distribuzione geografica
Continente #
NA - Nord America 6.669
EU - Europa 6.533
AS - Asia 2.705
SA - Sud America 43
OC - Oceania 29
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 9
Totale 16.012
Nazione #
US - Stati Uniti d'America 6.653
GB - Regno Unito 2.530
CN - Cina 1.697
SG - Singapore 716
DE - Germania 646
IT - Italia 633
SE - Svezia 600
RU - Federazione Russa 540
FR - Francia 488
IE - Irlanda 415
FI - Finlandia 379
UA - Ucraina 155
VN - Vietnam 76
TR - Turchia 43
BE - Belgio 38
IN - India 38
BR - Brasile 30
AU - Australia 28
IR - Iran 28
ID - Indonesia 25
CZ - Repubblica Ceca 21
KR - Corea 20
JP - Giappone 18
RO - Romania 14
CA - Canada 13
NL - Olanda 10
EU - Europa 9
HK - Hong Kong 8
GH - Ghana 7
GR - Grecia 7
LV - Lettonia 7
PL - Polonia 7
AT - Austria 6
NP - Nepal 6
SA - Arabia Saudita 6
CH - Svizzera 5
DK - Danimarca 5
ES - Italia 5
CL - Cile 4
EG - Egitto 4
ET - Etiopia 4
PE - Perù 4
AL - Albania 3
AR - Argentina 3
EE - Estonia 3
PT - Portogallo 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CM - Camerun 2
CO - Colombia 2
DZ - Algeria 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
TH - Thailandia 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
SY - Repubblica araba siriana 1
UG - Uganda 1
Totale 16.012
Città #
Southend 2.234
Jacksonville 1.282
Chandler 1.029
Woodbridge 823
Singapore 557
Ann Arbor 540
Dublin 415
Houston 355
Ashburn 354
Beijing 220
Wilmington 215
Jinan 190
Lawrence 179
Princeton 179
Nanjing 164
Shenyang 155
Hebei 102
New York 101
Boardman 100
Helsinki 76
Sindelfingen 70
Zhengzhou 66
Verona 61
Tianjin 60
Haikou 56
Seattle 56
Hangzhou 55
Taizhou 55
Nanchang 52
Changsha 51
Milan 49
Jiaxing 48
Dong Ket 45
Philadelphia 45
Ningbo 44
Falls Church 41
Fairfield 39
Guangzhou 38
Brussels 35
Cambridge 35
Rome 35
Taiyuan 31
Norwalk 30
Lanzhou 27
Fuzhou 25
Dearborn 24
Lancaster 24
Jakarta 23
Moscow 22
Redwood City 22
Santa Clara 22
Redmond 21
Seoul 20
Los Angeles 19
Bologna 17
Auburn Hills 16
Provo 16
Brno 15
Düsseldorf 15
Washington 15
Dallas 13
Perth 11
Tokyo 11
Leawood 10
San Francisco 10
Munich 9
São Paulo 9
Kent 8
Grafing 7
Kochi 7
Kumasi 7
Toronto 7
Zanjan 7
Ankara 6
Ardabil 6
Athens 6
Catania 6
Frankfurt am Main 6
Hong Kong 6
Kemerovo 6
San Diego 6
Tappahannock 6
Torino 6
Catanzaro 5
Clearwater 5
Hefei 5
Parsa 5
Addis Ababa 4
Andover 4
Arezzo 4
Canberra 4
Chicago 4
Dalmine 4
Dresden 4
Fremont 4
Genoa 4
Genova 4
Groningen 4
Jeddah 4
Lima 4
Totale 10.958
Nome #
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 327
Analisi del riarrangiamento bcr-abl in alcuni pazienti affetti da leucemia mieloide cronica 159
Linfomi del tessuto linfatico associato alle mucose (MALT) delle ghiandole salivari. Descrizione di un caso in un paziente con infezione da virus C dell'epatite e revisione della letteratura 148
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 144
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 143
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies 141
The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia 138
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia 136
A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders 134
Anemie iporigenerative ipercromiche e macrocitiche 129
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 128
B cells in chronic lymphocytic leukaemia. Comparative analysis of blood and bone marrow 127
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 127
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC. 125
[Clinical and pathological staging of 85 patients with Hodgkin's disease: a clinical contribution (author's transl)] 124
An unusual case of acute leukaemia 123
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 121
[The use of betamethasone in polychemotherapy of lymphoproliferative diseases] 121
Prognostic factors in acute non-lymphocytic leukemia with respect to treatment response 121
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 121
Blood smear, a key diagnostic tool in hematology: Lessons from two cases of acute hemolysis in previously undiagnosed g6pd deficiency 120
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 116
Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases 116
Folic acid binding protein in chronic granulocytic leukaemia: the effect of methotrexate 116
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 115
Leucemie 115
Unicentric Castleman's lymphadenopathy presenting with Behcet's syndrome: a case report 114
[Liver and spleen involvement in Hodgkin's disease: critical evaluation of diagnostic procedures (author's transl)] 114
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 114
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 114
Acute leukemia and pregnancy. Case report 113
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 113
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 113
Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML 111
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lymphoma 111
Soluble interleukin-2 receptor in the serum of patients with Hodgkin's Disease: A new biological marker of disease activity 110
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. 110
Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease 109
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 109
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 109
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations 109
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 108
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 108
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 107
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 106
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 106
2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma [see comments] 105
An assessment of chimeric transcript detection in CML patients after bone marrow transplantation 105
Bone marrow transplantation monitoring by DNA analysis 105
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 105
Valutazione del significato della cupremia come indice di attività e come segno precoce di ricaduta nel cancro della mammella e nel morbo di Hodgkin (studio su 270 Casi). 105
Terminal transferase expression in relapsed acute myeloid leukaemia 104
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment naive chronic lymphocytic leukemia 103
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia 102
Mycobacterial infections preceding hairy-cell leukemia diagnosis. Description of two cases 102
Pilot study of survival of patients with chronic myeloid leukemia after determination of intracellular folate binding protein (FABP) 102
CT imaging of primary pancreatic lymphoma: experience from three referral centres for pancreatic diseases 102
Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia. 101
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 101
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience 101
Immunohistologic study of bone marrow involvement in B-chronic lymphocytic leukemia 100
Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction 99
Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-a. 99
Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-alpha 99
Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia 98
Distribution and heterogeneity of cells detected by HNK-1 monoclonal antibody in blood and tissues in normal, reactive and neoplastic conditions 98
Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies 98
Regulation of the proliferative potential of cord blood long term culture initiating cells (LTC-IC) by different stromal cell lines: implications for LTC-IC measurement 97
Origin of the soluble interleukin 2 receptor in the serum of patients with hairy cell leukemia 97
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. 97
the International Extranodal Lymphoma Study group (IELSG). Intravascular lymphoma: clinical presentation, natural history, management, and prognostic factors in a series of 38 cases, with special emphasis on the “cutaneous variant”. 96
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor. 96
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 95
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 95
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma 95
Patterns of outcome and prognostic factors in primary large cell lymphoma of the testis in a survey of 373 patients by the International Extranodal Lymphoma Study Grfoup (IELSG). 94
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia 94
Remission of severe antiphospholipid syndrome associated with non Hodgkin's B-cell lymphoma after combined treatment with Rituximab and chemotherapy 92
Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. 91
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 91
Predictive factors of stable deep molecular response in chronic myeloid leukemia patients treated with imatinib standard dose: a study from the Gruppo Triveneto LMC. 91
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma 90
OFATUMUMAB AND LENALIDOMIDE PREFERENTIALLY INHIBIT B-CELL RECEPTOR SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS WITH MUTATED IGHV 90
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma 90
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response 88
Serum levels of soluble CD30 improve international prognostic score in predicting the outcome of advanced Hodgkin's lymphoma 87
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas. 87
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol 87
Specific and non specific folate binding protein in normal and malignant human tissues. 86
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 86
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis 86
CT IMAGING OF PRIMARY PANCREATIC LYMPHOMA 86
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis. 85
Soluble interleukin-2 receptor in hairy cell leukemia: A reliable marker of disease 85
Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy 84
The type of BCR/ABL junction does not predict the survival of patients with Ph1-positive chronic myeloid leukaemia 83
Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia 83
Stable hematological, cytogenetic and molecular remission in a splenectomised CML patient 22 years after diagnosis: analysis of cytokine production by PBMC subpopulations 83
Treatment of elderly Hodgkin's lymphoma patients. The experience of the Italian Lymphoma Intergroup 83
The role of autotransplantation in chronic lymphocytic leukemia and results from the italian group 83
Totale 10.830
Categoria #
all - tutte 49.908
article - articoli 40.600
book - libri 0
conference - conferenze 7.587
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.721
Totale 99.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.553 0 0 0 0 145 281 176 182 117 193 79 380
2020/20211.898 144 284 119 205 163 247 21 138 147 25 265 140
2021/20221.494 144 426 15 113 86 45 33 92 59 39 134 308
2022/20232.990 229 282 292 549 311 705 47 155 314 25 62 19
2023/20241.441 69 143 131 176 157 202 59 104 17 73 196 114
2024/20251.405 265 228 119 623 170 0 0 0 0 0 0 0
Totale 16.193